Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2023

Mar 1, 2023

29809_dirs_2023-03-01_12c6f590-5b87-4652-bf57-5856f1a74c28.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-02-28

Reporting Person: Charlton Henry L (Senior Vice President & Chief)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-28 Common Stock M 1449 $0.0 Acquired 20508 Direct
2023-02-28 Common Stock F 517 $229.39 Disposed 19991 Direct
2023-02-28 Common Stock M 752 $0.0 Acquired 20743 Direct
2023-02-28 Common Stock F 227 $229.39 Disposed 20516 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-28 Non-Qualified Stock Option (right to buy) $229.39 A 6464 Acquired 2030-02-27 Common Stock (6464) Direct
2023-02-28 Restricted Stock Units $0.0 M 752 Disposed 2026-02-28 Common Stock (752) Direct
2023-02-28 Restricted Stock Units $0.0 M 1449 Disposed 2030-02-28 Common Stock (1449) Direct
2023-02-28 Restricted Stock Units $0.0 A 4310 Acquired Common Stock (4310) Direct

Footnotes

F1: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

F3: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

F4: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.